Skip to main content
Retour
Watch Compare

Aimei Health Technology Co., Ltd.

Qualité des données : 67%
Également cotée sous AFJKU Nasdaq AFJKR Nasdaq
AFJK
Nasdaq Financial Services Holding & Investment Offices
62,00 €
▲ 33,00 € (113,79%)
Cap. Boursière: 379,55 M
Prix
62,00 €
Cap. Boursière
379,55 M
Fourchette du Jour
29,21 € — 85,00 €
Fourchette 52 Semaines
6,75 € — 130,37 €
Volume
465 021
Ouverture 29,21 €
Moyenne 50J / 200J
36,52 €
69,76% above
Moyenne 50J / 200J
23,86 €
159,87% above

Quick Summary

Points Clés

Earnings declined -93,28% over the past year
P/E of 117,10 — premium valuation

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-93,28%
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-1,14%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,01
Interest CoverageN/A

Valorisation

PE (TTM)
117,10
Au-dessus de la moyenne du secteur (11,15)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Financial Services (2153 pairs)
Métrique Action Médiane du Secteur
P/E 117,1 11,1
P/B — 1,2
ROE % — 9,2
Net Margin % — 9,4
Rev Growth 5Y % — 5,8
D/E — 0,5

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) -93,28% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) 3,24 M
ROE N/A ROA 7,20%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC -1,14% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,01
Interest Coverage N/A Asset Turnover N/A
Working Capital -2,75 M Tangible Book Value -3,44 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 117,10 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap 379,55 M Enterprise Value 379,55 M
Per Share
EPS (Diluted TTM) 0,08 Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2023 FY2024
Revenue — —
Net Income 171 389,0 2,55 M
EPS (Diluted) 0,08 —
Gross Profit — —
Operating Income -28 459,0 -1,06 M
EBITDA — —
R&D Expenses — —
SG&A Expenses — —
D&A — —
Interest Expense — —
Income Tax — 0,0

Balance Sheet

Annual, most recent first
Metric FY2023 FY2024
Total Assets 70,47 M 73,81 M
Total Liabilities 714 841,0 1,51 M
Shareholders' Equity -134 124,0 -1,48 M
Total Debt — —
Cash & Equivalents — —
Current Assets 580 717,0 30 384,0
Current Liabilities 24 841,0 816 994,0